Copyright
©The Author(s) 2021.
World J Hepatol. Jan 27, 2022; 14(1): 260-273
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.260
Published online Jan 27, 2022. doi: 10.4254/wjh.v14.i1.260
HBV DNA | HAI | Fibrosis | ||||
Parameters | < 6.65 | ≥ 6.65 | < 9 | ≥ 9 | < 4 | ≥ 4 |
n | 23 | 31 | 31 | 23 | 34 | 20 |
Age (yr) | 48.13 ± 10.34 | 45.71 ± 12.02 | 46.52 ± 11.73 | 47.04 ± 10.92 | 45.82 ± 11.63 | 48.30 ± 10.81 |
Gender | ||||||
Male | 10 (43.5) | 20 (64.5) | 19 (61.3) | 11 (47.8) | 23 (67.6) | 7 (35)a |
Female | 13 (56.5) | 11 (35.5) | 12 (38.7) | 12 (52.2) | 11 (32.4) | 13 (65) |
HBV DNA (log10IU/mL) | - | - | 4.97 ± 1.49 | 7.56 ± 1.21a | 4.16 ± 0.97 | 3.98 ± 0.93 |
HBsAg (log10IU/mL) | 3.19 ± 0.84 | 3.92 ± 0.90 | 3.30 ± 0.8 | 3.86 ± 0.91a | 3.46 ± 0.95 | 4.03 ± 0.98 |
ALT IU/L | 96.09 ± 33.55 | 163.06 ± 50.85a | 102.55 ± 41.36 | 177.65 ± 80.65 | 126.18 ± 64.87 | 148.75 ± 58.6 |
ALT < 200 IU/L | 21 (91.3) | 18 (58.1)b | 26 (83.9) | 13 (56.5)a | 25 (73.5) | 14 (70) |
ALT ≥ 200 IU/L | 2 (8.7) | 13 (41.9) | 5 (16.1) | 10 (43.5) | 9 (26.5) | 6 (30) |
INR | 1.13 ± 0.27 | 1.17 ± 0.28 | 1.15 ± 0.3 | 1.16 ± 0.24 | 1.22 ± 0.32 | 1.04 ± 0.10b |
Platelets (× 103/μL) | 234.91 ± 80.6 | 216.31 ± 61.29 | 237.67 ± 73.34 | 206.64 ± 73.34 | 218.21 ± 71.85 | 236.5 ± 68.79 |
HAI score ≥ 9 | 2 (8.7) | 21 (67.7)b | - | - | 14 (26.5) | 9 (70)b |
HAI score < 9 | 21 (91.3) | 10 (32.3) | - | - | 20 (73.5) | 11 (30) |
Fibrosis ≥ 4 | 4 (17.4) | 16 (51.6)a | 6 (19.4) | 14 (60.9)b | - | - |
Fibrosis < 4 | 19 (82.6) | 15 (48.4) | 25 (80.6) | 9 (39.1) | - | - |
p-HBsAg | 30.39 ± 14.18 | 31.91 ± 14.04 | 28.68 ± 11.16 | 34.75 ± 16.71 | 33.21 ± 15.32 | 27.96 ± 10.93 |
HBsAg SP1 | ||||||
A | 6 (26.1) | 10 (32.3) | 13 (41.9) | 3 (13)a | 13 (38.2) | 3 (15) |
B | 5 (21.7) | 9 (29) | 5 (16.1) | 9 (39.1) | 7 (20.6) | 7 (35) |
C | 4 (17.4) | 1 (3.2) | 4 (12.9) | 1 (4.3) | 5 (14.7) | 0 |
D | 5 (21.7) | 1 (3.2) | 5 (16.1) | 1 (4.3) | 3 (8.8) | 3 (15) |
E | 3 (13) | 10 (32.3) | 4 (12.9) | 9 (39.1) | 6 (17.6) | 7 (35) |
HBsAg SP2 | ||||||
Diffuse | 11(47.8) | 19 (61.3)b | 18 (58.1) | 12 (52.2)a | 20 (58.8) | 10 (50) |
Globular | 9 (39.1) | 2 (3.2) | 9 (29) | 1 (4.3) | 7 (20.6) | 3 (15) |
Submembranous | 3 (13.1) | 10 (31.5) | 4 (12.9) | 10 (43.5) | 7 (20.6) | 7 (35) |
Membranous expression | ||||||
Present | 7 (30.4) | 13 (41.9) | 10 (32.3) | 10 (43.5) | 14 (41.2) | 6 (30) |
Absent | 16 (69.6) | 18 (58.1) | 21 (67.7) | 13 (56.5) | 20 (58.8) | 14 (70) |
- Citation: Alpsoy A, Adanir H, Bayramoglu Z, Elpek GO. Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study. World J Hepatol 2022; 14(1): 260-273
- URL: https://www.wjgnet.com/1948-5182/full/v14/i1/260.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i1.260